Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Kumanan Wilson a Division of General Internal Medicine,
University of Ottawa, Ottawa, Ontario, Canada, b Department of Medicine, Ottawa
Hospital Correspondence to: K Wilson, Civic Parkdale Clinic,
737 Parkdale Avenue, Suite 414, Ottawa, Ontario, Canada K1Y 1J8 kwilson{at}lri.ca
Objective:
To determine the strength of association
between history of blood transfusion and development of
Creutzfeldt-Jakob disease.
Civic Campus, 1053 Carling Avenue, Ottawa, Ontario K1Y
4E9, c Room L410, Department of Surveillance and Response, World
Health Organization, Avenue Appia, CH-1211, Geneva 27, Switzerland
Data sources:
English and non-English language
articles published from January 1966 to January 1999 were retrieved
using a keyword search of Medline and Embase. These were supplemented by handsearching key journals and searching bibliographies of reviews.
Study selection:
Two independent reviewers selected
the relevant abstracts and articles. Articles were chosen that reported
the results of case-control studies trying to identify rates of prior blood transfusion in patients with Creutzfeldt-Jakob disease and in controls.
Data extraction:
Odds ratios and information on study
quality were extracted from the selected articles by two independent reviewers.
Data synthesis:
Five studies containing data on 2479 patients were included. Three of the five studies used medical or
neurological patients as controls, the other two used population
controls. Odds ratios for developing Creutzfeldt-Jakob disease from
blood transfusion ranged from 0.54 to 0.89. Four of the five studies had confidence intervals that crossed 1.0. The combined odds ratio was
0.70 (95% confidence interval 0.54 to 0.89).
Conclusions:
Case-control studies do not suggest a
risk of developing Creutzfeldt-Jakob disease from blood transfusion. Rather, a trend seems to exist towards a lower frequency of previous blood transfusion in patients with Creutzfeldt-Jakob disease than in
controls. However, it is important to be aware of these studies' methodological limitations
primarily the choice of control population and reliability of recall of transfusion status.
Read all Rapid Responses